Home > Insider Trading > Filing (0000950142-15-000194)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	244106690

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	C/O Aisling Capital 888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No
1250195	Steve Elms	C/O Aisling Capital 888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No
1297291	J Dennis Purcell	C/O Aisling Capital 888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No
1444717	Aisling Capital Iii Lp	888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No
1532634	Aisling Capital Partners Iii Lp	888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No
1532635	Aisling Capital Partners Iii Llc	888 Seventh Ave., 30Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-27	145,000	$17.25	2,139,568	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See FN

Footnotes

The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.